Danazol in Treating Patients With Advanced or Recurrent Endometrial Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00003946
Recruitment Status : Completed
First Posted : June 25, 2004
Last Update Posted : June 10, 2013
National Cancer Institute (NCI)
Information provided by:
Gynecologic Oncology Group

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : June 2003
  Study Completion Date : No date given